EFG Asset Management (Americas)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.54M | Buy |
|
|||||
|
2024
Q1 | $1.73M | Sell |
|
|||||
|
2023
Q4 | $2.63M | Buy |
|
|||||
|
2023
Q3 | $2.37M | Buy |
|
|||||
|
2023
Q2 | $1.44M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $261K | Sell |
|
|||||
|
2020
Q3 | $231K | Sell |
|
|||||
|
2020
Q2 | $4.76M | Sell |
|
|||||
|
2020
Q1 | $4.14M | Sell |
|
|||||
|
2019
Q4 | $4.68M | Buy |
|
|||||
|
2019
Q3 | $2.3M | Sell |
|
|||||
|
2019
Q2 | $2.97M | Buy |
|
|||||
|
2019
Q1 | $3.03M | Sell |
|
|||||
|
2018
Q4 | $3.36M | Buy |
|
|||||
|
2018
Q3 | $3.44M | Buy |
|
|||||
|
2018
Q2 | $2.73M | Buy |
|
|||||
|
2018
Q1 | $946K | Buy |
|
|||||
|
2017
Q4 | $929K | Buy |
|
|||||
|
2017
Q3 | $684K | Buy |
|
|||||
|
2017
Q2 | $505K | Buy |
|
|||||
|
2017
Q1 | $315K | Buy |
|